Health Canada has recalled a topical prescription medication used to relieve itching and inflammation caused by common conditions such as eczema, psoriasis and dermatitis.
The recall affects certain lots of Ratio-Ectoson (Teva-Ectosone) 0.05% mild lotion, a corticosteroid treatment sold in 60 ml bottles with Drug Identification Number (DIN) 00653209 and lot number 688519. The product is due to expire this month.
Teva Canada, the manufacturer of the lotion, said in a statement that testing of the affected products revealed they contained higher than acceptable levels of an impurity called betamethasone enol aldehyde.
“These impurities can form through chemical changes in the medicine during storage and may pose health risks, including being absorbed into the bloodstream and potentially causing adverse reactions on the skin or other parts of the body,” the Health Canada statement said.
“Children may be at even higher risk because they absorb more impurities and are more susceptible to adverse reactions.”
Health Canada
The affected bottles of eczema lotion were distributed to pharmacies across Canada between November 24, 2022 and March 22, 2023.
If you have any of the affected lotions, discontinue use. If you have used the product on yourself or your child and have health concerns, consult a medical professional.
Do not give away or sell your product. This is prohibited under the Canadian Consumer Product Safety Act. Instead, return it to your local pharmacy and dispose of it properly.
Health Canada said it is currently monitoring Teva Canada's implementation of necessary corrective and preventive actions to prevent the problem from recurring. If you have questions about the recall, you can contact the company toll-free at 1-800-268-4129.
Report any side effects or complaints related to health products to the Federal Health Authority and subscribe to recall updates by clicking this link.
